Roivant Sciences (ROIV) Shares Outstanding (2020 - 2026)

Roivant Sciences (ROIV) has 7 years of Shares Outstanding (Entity) data on file, last reported at $720.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 3.51% year-over-year to $720.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $720.4 million (up 3.51% YoY) and the FY2026 annual result came in at $720.4 million, up 3.51% from the prior year.
• Shares Outstanding (Entity) climbed to $720.4 million in Q1 2026, from $709.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $806.7 million in Q1 2024 to a low of $682.2 million in Q2 2025.
• A 5-year average of $732.8 million and a median of $720.4 million in 2026 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 215.73% — and 2025, when it retreated 13.73%.
• Tracing ROIV's Shares Outstanding (Entity) over 5 years: stood at $726.8 million in 2022, then advanced by 10.74% to $804.9 million in 2023, then slipped by 10.59% to $719.6 million in 2024, then declined by 1.38% to $709.7 million in 2025, then advanced by 1.5% to $720.4 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $720.4 million (Q1 2026), $709.7 million (Q4 2025), and $689.7 million (Q3 2025), per Business Quant data.